Versant Ventures Iii, Llc - Net Worth and Insider Trading
Versant Ventures Iii, Llc Net Worth
The estimated net worth of Versant Ventures Iii, Llc is at least $36 Million dollars as of 2024-05-22. Versant Ventures Iii, Llc is the 10% Owner of Flexion Therapeutics Inc and owns about 3,921,092 shares of Flexion Therapeutics Inc (FLXN) stock worth over $36 Million. Versant Ventures Iii, Llc is also the 10% Owner of OpGen Inc and owns about 26 shares of OpGen Inc (OPGN) stock worth over $90. Details can be seen in Versant Ventures Iii, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Versant Ventures Iii, Llc has not made any transactions after 2016-06-08 and currently still holds the listed stock(s).
Transaction Summary of Versant Ventures Iii, Llc
Versant Ventures Iii, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Versant Ventures Iii, Llc owns 5 companies in total, including Flexion Therapeutics Inc (FLXN) , PhaseRx Inc (PZRXQ) , and OpGen Inc (OPGN) among others .
Click here to see the complete history of Versant Ventures Iii, Llc’s form 4 insider trades.
Insider Ownership Summary of Versant Ventures Iii, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2016-06-08 | 10 percent owner |
| PZRXQ | PhaseRx Inc | 2016-05-23 | 10 percent owner |
| OPGN | OpGen Inc | 2015-05-08 | 10 percent owner |
 | | 2013-10-29 | 10 percent owner |
| | 2023-08-18 | 10 percent owner |
Versant Ventures Iii, Llc Latest Holdings Summary
Versant Ventures Iii, Llc currently owns a total of 2 stocks. Among these stocks, Versant Ventures Iii, Llc owns 3,921,092 shares of Flexion Therapeutics Inc (FLXN) as of June 8, 2016, with a value of $36 Million and a weighting of 100%. Versant Ventures Iii, Llc also owns 26 shares of OpGen Inc (OPGN) as of May 8, 2015, with a value of $90 and a weighting of 0%.
Latest Holdings of Versant Ventures Iii, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2016-06-08 | 3,921,092 | 9.12 | 35,760,359 |
| OPGN | OpGen Inc | 2015-05-08 | 26 | 3.48 | 90 |
Holding Weightings of Versant Ventures Iii, Llc
Versant Ventures Iii, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Versant Ventures Iii, Llc has made a total of 0 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years. The most-recent trade in Flexion Therapeutics Inc is the acquisition of 714,285 shares on June 8, 2016, which cost Versant Ventures Iii, Llc around $10 Million.
According to the SEC Form 4 filings, Versant Ventures Iii, Llc has made a total of 0 transactions in OpGen Inc (OPGN) over the past 5 years. The most-recent trade in OpGen Inc is the acquisition of 4 shares on May 8, 2015, which cost Versant Ventures Iii, Llc around $2 Million.
Insider Trading History of Versant Ventures Iii, Llc
- 1
Versant Ventures Iii, Llc Trading Performance
GuruFocus tracks the stock performance after each of Versant Ventures Iii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Versant Ventures Iii, Llc is -4.9%. GuruFocus also compares Versant Ventures Iii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Versant Ventures Iii, Llc within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Versant Ventures Iii, Llc's insider trading performs compared to the benchmark.
Performance of Versant Ventures Iii, Llc
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 8.88 | | | | | |
| Relative Return to S&P 500(%) | 9.49 | | | | | |
Versant Ventures Iii, Llc Ownership Network
Versant Ventures Iii, Llc Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
Versant Ventures Iii, Llc is the 10 percent owner of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , Chief Strategy Officer Christina Willwerth , and General Counsel Mark S. Levine .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
Versant Ventures Iii, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Versant Ventures Iii, Llc. You might contact Versant Ventures Iii, Llc via mailing address: One Sansome Street, Suite 1650, San Francisco Ca 94104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
